Table 1: Demographic and Clinical Characteristics - nsaid
	Total	non-current NSAID use	current NSAID use

1	  2459762 (100.0)	  1924217 (100.0)	  535,545 (100.0)

Grouped age
1	  712,103 (29.0)	  596,624 (31.0)	  115,479 (21.6)
2	  499,103 (20.3)	  396,298 (20.6)	  102,805 (19.2)
3	  556,529 (22.6)	  423,627 (22.0)	  132,902 (24.8)
4	  389,795 (15.8)	  283,621 (14.7)	  106,174 (19.8)
5	  231,493 (9.4)	  169,302 (8.8)	   62,191 (11.6)
6	   70,739 (2.9)	   54,745 (2.8)	   15,994 (3.0)

Male
0	  1408581 (57.3)	  1091724 (56.7)	  316,857 (59.2)
1	  1051181 (42.7)	  832,493 (43.3)	  218,688 (40.8)

Grouped BMI
1	   32,131 (1.3)	   26,204 (1.4)	    5,927 (1.1)
2	  597,363 (24.3)	  483,089 (25.1)	  114,274 (21.3)
3	  734,701 (29.9)	  575,592 (29.9)	  159,109 (29.7)
4	  437,627 (17.8)	  331,701 (17.2)	  105,926 (19.8)
5	  187,463 (7.6)	  137,234 (7.1)	   50,229 (9.4)
6	  100,692 (4.1)	   70,565 (3.7)	   30,127 (5.6)
.	  369,785 (15.0)	  299,832 (15.6)	   69,953 (13.1)

Smoking status
1	  1059019 (43.1)	  839,279 (43.6)	  219,740 (41.0)
2	  872,591 (35.5)	  665,218 (34.6)	  207,373 (38.7)
3	  491,388 (20.0)	  388,414 (20.2)	  102,974 (19.2)
.	   36,764 (1.5)	   31,306 (1.6)	    5,458 (1.0)

Smoking status (missing set to non)
1	  1095783 (44.5)	  870,585 (45.2)	  225,198 (42.1)
2	  872,591 (35.5)	  665,218 (34.6)	  207,373 (38.7)
3	  491,388 (20.0)	  388,414 (20.2)	  102,974 (19.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Ethnicity
1	  1585111 (64.4)	  1229701 (63.9)	  355,410 (66.4)
2	   25,123 (1.0)	   20,451 (1.1)	    4,672 (0.9)
3	  184,796 (7.5)	  151,759 (7.9)	   33,037 (6.2)
4	   59,988 (2.4)	   49,467 (2.6)	   10,521 (2.0)
5	   37,103 (1.5)	   30,181 (1.6)	    6,922 (1.3)
.	  567,641 (23.1)	  442,658 (23.0)	  124,983 (23.3)

Index of Multiple Deprivation (IMD)
1	  494,432 (20.1)	  387,292 (20.1)	  107,140 (20.0)
2	  494,012 (20.1)	  385,519 (20.0)	  108,493 (20.3)
3	  488,284 (19.9)	  381,078 (19.8)	  107,206 (20.0)
4	  491,528 (20.0)	  384,767 (20.0)	  106,761 (19.9)
5	  491,506 (20.0)	  385,561 (20.0)	  105,945 (19.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  2222981 (90.4)	  1747157 (90.8)	  475,824 (88.8)
2	  164,271 (6.7)	  122,322 (6.4)	   41,949 (7.8)
3	   66,682 (2.7)	   50,211 (2.6)	   16,471 (3.1)
4	    5,828 (0.2)	    4,527 (0.2)	    1,301 (0.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)



Diagnosed hypertension
1	  482,254 (19.6)	  354,161 (18.4)	  128,093 (23.9)

Heart Failure
1	   11,904 (0.5)	    9,477 (0.5)	    2,427 (0.5)

Other Heart Diseases
1	   36,734 (1.5)	   28,010 (1.5)	    8,724 (1.6)

Diabetes
1	  236,781 (9.6)	  177,060 (9.2)	   59,721 (11.2)

COPD
1	   58,143 (2.4)	   42,689 (2.2)	   15,454 (2.9)

Other Respiratory Diseases
1	   23,521 (1.0)	   17,326 (0.9)	    6,195 (1.2)

Cancer
1	  127,404 (5.2)	   95,263 (5.0)	   32,141 (6.0)

Immunosuppressed (combination algorithm)
1	   53,353 (2.2)	   42,663 (2.2)	   10,690 (2.0)

Chronic kidney disease
1	   69,266 (2.8)	   51,696 (2.7)	   17,570 (3.3)

Osteoarthritis
1	  531,629 (21.6)	  368,746 (19.2)	  162,883 (30.4)

Rheumatoid arthritis
1	   50,044 (2.0)	   28,616 (1.5)	   21,428 (4.0)

Flu vaccine
1	  596,913 (24.3)	  435,010 (22.6)	  161,903 (30.2)

Pneumococcal Vaccine
1	  161,188 (6.6)	  116,379 (6.0)	   44,809 (8.4)

Recent Statin
1	  311,060 (12.6)	  223,777 (11.6)	   87,283 (16.3)

Recent PPIs
1	  610,978 (24.8)	  268,828 (14.0)	  342,150 (63.9)

Recent oral prednisolone
1	   55,036 (2.2)	   38,996 (2.0)	   16,040 (3.0)

Recent hydroxychloroquine
1	   14,751 (0.6)	    8,077 (0.4)	    6,674 (1.2)

Recent Other DMARDs use
1	   37,534 (1.5)	   20,745 (1.1)	   16,789 (3.1)

GP consultation in last year (binary)
1	  2243522 (91.2)	  1719398 (89.4)	  524,124 (97.9)

A&E attendance rate in last year (binary)
1	  477,732 (19.4)	  363,721 (18.9)	  114,011 (21.3)

GP consultation count
Median (IQR)	6 (3-11)	5 (2-10)	8 (4-13)
Min, Max	0, 626	0, 626	0, 560
Age (years)
Median (IQR)	50 (37-61)	49 (36-60)	53 (42-64)
Min, Max	18, 110	18, 110	18, 103
A&E attendance count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-0)
Min, Max	0, 153	0, 127	0, 153
Number of days (follow-up) for ONS covid death
Median (IQR)	105 (105-105)	105 (105-105)	105 (105-105)
Min, Max	1, 105	1, 105	1, 105
